Brief Report: Leucine‐Rich α<sub>2</sub>‐Glycoprotein as a Potential Biomarker for Joint Inflammation During Anti–Interleukin‐6 Biologic Therapy in Rheumatoid Arthritis
Distribution of the number of citations over years.